Both draft guidance documents can be found below, including the committee’s estimate of the value of these to the NHS:
BSAC welcomes news that these two ‘last line of defence’ antibiotics will soon be available on the NHS as part of a new de-linkage scheme. See full details and comments from Dr David Jenkins, President of the British Society for Antimicrobial Chemotherapy.